AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 18 filers reported holding AEGERION PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,686,000 | -52.6% | 3,400 | -51.4% | 0.18% | -62.2% |
| Q1 2017 | $5,670,000 | +30.3% | 7,000 | +16.7% | 0.47% | +14.6% |
| Q4 2016 | $4,350,000 | -47.7% | 6,000 | -27.9% | 0.41% | +1687.0% |
| Q3 2016 | $8,325,000 | +395.5% | 8,325 | -99.7% | 0.02% | -89.6% |
| Q2 2016 | $1,680,000 | – | 3,000,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 1,500,000 | $1,219,000 | 0.82% |
| EdgePoint Investment Group Inc. | 51,642,000 | $41,704,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,600,000 | $13,359,000 | 0.60% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 43,150,000 | $34,952,000 | 0.52% |
| Tekla Capital Management LLC | 13,000,000 | $10,303,000 | 0.37% |
| UBS OCONNOR LLC | 26,000,000 | $20,669,000,000 | 0.30% |
| Orbimed Advisors | 15,000,000 | $12,151,000 | 0.12% |
| Baker Brothers Advisors | 9,517,000 | $7,576,000 | 0.06% |
| CSS LLC/IL | 653,000 | $517,000 | 0.02% |
| Allianz Asset Management GmbH | 28,680,000 | $23,232,000 | 0.02% |